BNP PARIBAS FINANCIAL MARKETS - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$197
-99.8%
232
+134.3%
0.00%
Q3 2022$81,000
-93.3%
99
-91.9%
0.00%
Q2 2022$1,212,000
+8557.1%
1,224
+30500.0%
0.00%
Q4 2020$14,000
-12.5%
40.0%0.00%
Q3 2020$16,000
+45.5%
40.0%0.00%
Q2 2020$11,000
-93.4%
4
-94.9%
0.00%
Q1 2020$167,000
-61.2%
790.0%0.00%
Q4 2019$430,000
-92.1%
79
-95.6%
0.00%
Q3 2019$5,436,000
-19.5%
1,8060.0%0.00%
Q2 2019$6,754,000
-46.5%
1,806
-42.5%
0.00%
Q1 2019$12,635,000
+1547.3%
3,143
+1403.8%
0.00%
Q4 2018$767,000
-78.6%
209
-50.0%
0.00%
Q3 2018$3,586,000
-32.5%
418
-13.6%
0.00%
Q2 2018$5,314,000
-73.0%
484
-71.7%
0.00%
Q1 2018$19,705,000
+12.1%
1,709
+0.8%
0.00%
Q4 2017$17,571,000
+93.4%
1,696
+197.5%
0.00%
Q3 2017$9,086,000
+97.6%
570
+50.0%
0.00%
Q2 2017$4,598,000
+3578.4%
380
+6233.3%
0.00%
Q1 2017$125,000
-79.7%
6
-86.0%
0.00%
Q4 2016$615,000
-83.4%
43
-80.9%
0.00%
Q3 2016$3,701,000
+98.1%
225
+71.8%
0.00%
Q2 2016$1,868,0001310.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$11,661,0002.42%
Telemetry Investments, L.L.C. 189,081$673,0001.14%
CHI Advisors LLC 490,877$1,748,0000.49%
BVF INC/IL 1,943,712$6,920,0000.27%
Orbimed Advisors 6,767,584$24,093,0000.21%
Novo Holdings A/S 847,906$3,019,0000.13%
Golden Green, Inc. 19,539$70,0000.06%
ALGERT GLOBAL LLC 15,467$55,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,700$476,0000.01%
Hikari Power Ltd 19,959$71,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders